Cambridge Trust CO Abbott Laboratories Transaction History

Cambridge Trust CO

  • $2.6 Billion
  • Q1 2024

A detailed history of Cambridge Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Cambridge Trust CO holds 44,143 shares of ABT stock, worth $5.2 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
44,143
Previous 45,717 3.44%
Holding current value
$5.2 Million
Previous $5.03 Million 0.3%
% of portfolio
0.19%
Previous 0.21%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 30, 2024
SELL
$109.52 - $120.96 $172,384 - $190,391
-1,574 Reduced 3.44%
44,143 $5.02 Million
Q4 2023

Jan 31, 2024
SELL
$90.19 - $110.4 $15,963 - $19,540
-177 Reduced 0.39%
45,717 $5.03 Million
Q3 2023

Oct 26, 2023
SELL
$95.53 - $114.62 $326,712 - $392,000
-3,420 Reduced 6.94%
45,894 $4.44 Million
Q2 2023

Jul 25, 2023
SELL
$100.78 - $112.29 $493,318 - $549,659
-4,895 Reduced 9.03%
49,314 $5.38 Million
Q1 2023

May 12, 2023
SELL
$96.86 - $114.01 $197,981 - $233,036
-2,044 Reduced 3.63%
54,209 $5.49 Million
Q4 2022

Jan 09, 2023
SELL
$95.06 - $111.52 $103,710 - $121,668
-1,091 Reduced 1.9%
56,253 $6.18 Million
Q3 2022

Nov 07, 2022
SELL
$96.76 - $112.03 $576,012 - $666,914
-5,953 Reduced 9.4%
57,344 $5.55 Million
Q2 2022

Aug 16, 2022
SELL
$102.07 - $123.37 $513,310 - $620,427
-5,029 Reduced 7.36%
63,297 $6.88 Million
Q1 2022

May 12, 2022
SELL
$114.02 - $139.04 $276,042 - $336,615
-2,421 Reduced 3.42%
68,326 $8.09 Million
Q4 2021

Feb 14, 2022
BUY
$115.53 - $141.46 $635,761 - $778,454
5,503 Added 8.43%
70,747 $9.96 Million
Q3 2021

Nov 23, 2021
BUY
$116.66 - $129.06 $496,271 - $549,021
4,254 Added 6.97%
65,244 $7.71 Million
Q3 2021

Nov 16, 2021
SELL
$116.66 - $129.06 $936,079 - $1.04 Million
-8,024 Reduced 11.63%
60,990 $7.21 Million
Q2 2021

Aug 16, 2021
SELL
$105.79 - $124.53 $269,447 - $317,177
-2,547 Reduced 3.56%
69,014 $8 Million
Q1 2021

May 14, 2021
BUY
$108.84 - $128.23 $457,672 - $539,207
4,205 Added 6.24%
71,561 $8.58 Million
Q4 2020

Jan 27, 2021
SELL
$105.0 - $114.42 $550,620 - $600,018
-5,244 Reduced 7.22%
67,356 $7.38 Million
Q3 2020

Nov 03, 2020
SELL
$91.64 - $111.29 $152,855 - $185,631
-1,668 Reduced 2.25%
72,600 $7.9 Million
Q2 2020

Aug 05, 2020
BUY
$76.57 - $98.0 $355,514 - $455,014
4,643 Added 6.67%
74,268 $7.42 Million
Q1 2020

May 04, 2020
SELL
$62.82 - $91.86 $166,975 - $244,163
-2,658 Reduced 3.68%
69,625 $5.49 Million
Q4 2019

Feb 04, 2020
BUY
$78.51 - $87.4 $216,138 - $240,612
2,753 Added 3.96%
72,283 $6.28 Million
Q3 2019

Nov 06, 2019
SELL
$81.84 - $88.74 $62,034 - $67,264
-758 Reduced 1.08%
69,530 $5.82 Million
Q2 2019

Jul 29, 2019
SELL
$72.88 - $85.0 $874 - $1,020
-12 Reduced 0.02%
70,288 $0
Q1 2019

Apr 22, 2019
SELL
$66.22 - $80.06 $85,291 - $103,117
-1,288 Reduced 1.8%
70,300 $5.62 Million
Q4 2018

Feb 04, 2019
SELL
$65.56 - $74.27 $991,529 - $1.12 Million
-15,124 Reduced 17.44%
71,588 $5.18 Million
Q3 2018

Oct 22, 2018
SELL
$60.81 - $73.36 $112,680 - $135,936
-1,853 Reduced 2.09%
86,712 $6.36 Million
Q2 2018

Aug 06, 2018
SELL
$57.57 - $63.54 $286,698 - $316,429
-4,980 Reduced 5.32%
88,565 $5.4 Million
Q1 2018

Apr 27, 2018
BUY
$56.27 - $63.62 $5,514 - $6,234
98 Added 0.1%
93,545 $5.61 Million
Q4 2017

Jan 24, 2018
SELL
$53.68 - $57.47 $81,271 - $87,009
-1,514 Reduced 1.59%
93,447 $0
Q3 2017

Nov 02, 2017
BUY
$48.06 - $53.64 $4.56 Million - $5.09 Million
94,961
94,961 $0

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cambridge Trust CO Portfolio

Follow Cambridge Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email